Syndax Pharmaceuticals, Inc. (SNDX) vs Stoke Therapeutics, Inc. (STOK)
Syndax Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. are both Biotechnology companies. Syndax Pharmaceuticals, Inc. and Stoke Therapeutics, Inc. are of similar size ($1.6B and $1.6B). Syndax Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 222.3% against −86.2%. Syndax Pharmaceuticals, Inc. has the higher net margin (−87.6% vs −753.6%) and the higher return on invested capital (−247.9% vs −264.8%). Across the 17 metrics below, Syndax Pharmaceuticals, Inc. leads on 9 and Stoke Therapeutics, Inc. on 8.
Valuation
Profitability
| Metric | SNDX | STOK | Biotechnology median |
|---|---|---|---|
| Gross margin | 95.78% | 100.00% | 65.16% |
| Operating margin | (77.05%) | (809.69%) | 0.00% |
| Net margin | (87.60%) | (753.60%) | 0.00% |
| Free cash flow margin | (87.64%) | (654.92%) | 0.00% |
| Return on equity | (255.93%) | (61.10%) | (57.72%) |
| Return on assets | (33.97%) | (53.41%) | (49.22%) |
| Return on invested capital | (247.93%) | (264.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack